Suzhou MedicalSystem Technology Co

Suzhou MedicalSystem Technology Co OCF Margin

The Operating Cash Flow Margin of Suzhou MedicalSystem Technology Co (603990.SS) as of Oct 23, 2026 is 21.83 %. In the previous year, Operating Cash Flow Margin was -2.45 % — a change of -989.27% (higher).

OCF Margin

21.83 %

YoY

-989.27%

Last updated:

Operating Cash Flow Margin of Suzhou MedicalSystem Technology Co is 2025 21.83 % . Operating Cash Flow Margin of Suzhou MedicalSystem Technology Co was 2024 -2.45 % . It decreases by -989.27% higher compared to the previous year.

The Suzhou MedicalSystem Technology Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
17.12 CNY
Jan 1, 2019
6.62 CNY
Jan 1, 2020
32.61 CNY
Jan 1, 2021
10.18 CNY
Jan 1, 2022
16.53 CNY
Jan 1, 2023
-51.23 CNY
Jan 1, 2024
-2.45 CNY
Jan 1, 2025
21.83 CNY
The Suzhou MedicalSystem Technology Co OCF Margin history
YEAROCF MarginYoY
21.83 %-989.27%
-2.45 %-95.21%
-51.23 %-409.82%
16.53 %+62.35%
10.18 %-68.77%
32.61 %+392.93%
6.62 %-61.35%
17.12 %-846.82%
-2.29 %-116.94%
13.53 %-27.24%
18.59 %-17.79%
22.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Suzhou MedicalSystem Technology Co Stock analysis

What does Suzhou MedicalSystem Technology Co do? Suzhou MedicalSystem Technology Co Ltd develops and sells the DoCare series of clinical medical management information system application software, which includes specialized systems for anesthesia, intensive care, pre-hospital emergency, blood purification, and clinical pathways. The company also offers overall solutions for clinical information systems, specifically the Dorico digital operating room and Dorico digital emergency first aid platform. These products are sold to healthcare institutions seeking comprehensive digital solutions for clinical operations and patient care management. The DoCare series targets hospitals and medical facilities requiring specialized clinical information systems, while the Dorico digital solutions cater to advanced healthcare environments needing integrated digital infrastructure. Both product lines are designed to enhance clinical efficiency and patient outcomes through tailored software applications and system integration. The company's offerings are positioned to meet the growing demand for digitized healthcare management within China's expanding medical sector. Suzhou MedicalSystem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Suzhou MedicalSystem Technology Co stock

Operating Cash Flow Margin of Suzhou MedicalSystem Technology Co is 21.83 % in 2025.

Operating Cash Flow Margin of Suzhou MedicalSystem Technology Co changed from -2.45 % to 21.83 %, representing a -989.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Suzhou MedicalSystem Technology Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Suzhou MedicalSystem Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Suzhou MedicalSystem Technology Co

All Key Metrics — Suzhou MedicalSystem Technology Co